Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Nplate

02 8Romiplate

PharmaCompass

01

Brand Name : Nplate

Romiplostim

arrow
CTAD25
Not Confirmed

Brand Name : Nplate

arrow
CTAD25
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 850

2019 Revenue in Millions : 795

Growth (%) : 7

blank

02

Brand Name : Nplate

Romiplostim

arrow
CTAD25
Not Confirmed

Brand Name : Nplate

arrow
CTAD25
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 1,027

2020 Revenue in Millions : 850

Growth (%) : 21

blank

03

Brand Name : Romiplate

Romiplostim

arrow
CTAD25
Not Confirmed

04

Brand Name : Romiplate

Romiplostim

arrow
CTAD25
Not Confirmed

05

Brand Name : Nplate

Romiplostim

arrow
CTAD25
Not Confirmed

Brand Name : Nplate

arrow
CTAD25
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 1,307

2021 Revenue in Millions : 1,027

Growth (%) : 27

blank

06

Brand Name : Romiplate

Romiplostim

arrow
CTAD25
Not Confirmed

07

Brand Name : Nplate

Romiplostim

arrow
CTAD25
Not Confirmed

Brand Name : Nplate

arrow
CTAD25
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2023 Revenue in Millions : 1,477

2022 Revenue in Millions : 1,307

Growth (%) : 13

blank

08

Brand Name : Romiplate

Romiplostim

arrow
CTAD25
Not Confirmed

09

Brand Name : Nplate

Romiplostim

arrow
CTAD25
Not Confirmed

Brand Name : Nplate

arrow
CTAD25
Not Confirmed

Romiplostim

Main Therapeutic Indication : Immunology

Currency : USD

2024 Revenue in Millions : 1,456

2023 Revenue in Millions : 1,477

Growth (%) : -1

blank

10

Brand Name : Romiplate

Romiplostim

arrow
CTAD25
Not Confirmed